Selected research
Industry Research
Ion Channel Modulators Industry Research Report 2026
Market perspective
The global Ion Channel Modulators market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Ion Channel Modulators market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Ion Channel Modulators market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Ion Channel Modulators market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Ion Channel Modulators include Sanofi (France), Pfizer, Inc. (US), GlaxoSmithKline Plc. (UK), AstraZeneca (UK), Zalicus, Inc. (US), Xention Limited (UK), Targacept, Inc. (US), Parion Sciences, Inc. (US) and Novartis AG (Switzerland), among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Ion Channel Modulators market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Ion Channel Modulators.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ion Channel Modulators Market by Company
Sanofi (France)
Pfizer, Inc. (US)
GlaxoSmithKline Plc. (UK)
AstraZeneca (UK)
Zalicus, Inc. (US)
Xention Limited (UK)
Targacept, Inc. (US)
Parion Sciences, Inc. (US)
Novartis AG (Switzerland)
Neusentis, Inc. (US)
NeuroSearch A/S (Denmark)
Nanion Technologies GmbH (Germany)
flyion GmbH (Germany)
Evotec AG (Germany)
Cytocentrics AG (Germany)
Convergence Pharmaceuticals Limited (UK)
Cellectricon AB (Sweden)
CalciMedica, Inc. (US)
Aurora Biomed, Inc. (Canada)
Ion Channel Modulators Segment by Type
Channel Blockers
Channel Openers
Ion Channel Modulators Segment by Application
Clinical Trials
Hospital
Other
Ion Channel Modulators Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ion Channel Modulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ion Channel Modulators and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ion Channel Modulators.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Ion Channel Modulators companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Channel Blockers
- Channel Openers
Applications
- Clinical Trials
- Hospital
- Other
Companies covered
- Sanofi (France)
- Pfizer, Inc. (US)
- GlaxoSmithKline Plc. (UK)
- AstraZeneca (UK)
- Zalicus, Inc. (US)
- Xention Limited (UK)
- Targacept, Inc. (US)
- Parion Sciences, Inc. (US)
- Novartis AG (Switzerland)
- Neusentis, Inc. (US)
- NeuroSearch A/S (Denmark)
- Nanion Technologies GmbH (Germany)
- flyion GmbH (Germany)
- Evotec AG (Germany)
- Cytocentrics AG (Germany)
- Convergence Pharmaceuticals Limited (UK)
- Cellectricon AB (Sweden)
- CalciMedica, Inc. (US)
- Aurora Biomed, Inc. (Canada)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Ion Channel Modulators by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Channel Blockers
- 2.2.3 Channel Openers
- 2.3 Ion Channel Modulators by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinical Trials
- 2.3.3 Hospital
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Ion Channel Modulators Breakdown Data by Type
- 3.1 Global Ion Channel Modulators Historic Market Size by Type (2021-2026)
- 3.2 Global Ion Channel Modulators Forecasted Market Size by Type (2027-2032)
4 Ion Channel Modulators Breakdown Data by Application
- 4.1 Global Ion Channel Modulators Historic Market Size by Application (2021-2026)
- 4.2 Global Ion Channel Modulators Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Ion Channel Modulators Market Perspective (2021-2032)
- 5.2 Global Ion Channel Modulators Growth Trends by Region
- 5.2.1 Global Ion Channel Modulators Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Ion Channel Modulators Historic Market Size by Region (2021-2026)
- 5.2.3 Ion Channel Modulators Forecasted Market Size by Region (2027-2032)
- 5.3 Ion Channel Modulators Market Dynamics
- 5.3.1 Ion Channel Modulators Industry Trends
- 5.3.2 Ion Channel Modulators Market Drivers
- 5.3.3 Ion Channel Modulators Market Challenges
- 5.3.4 Ion Channel Modulators Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Ion Channel Modulators Players by Revenue
- 6.1.1 Global Top Ion Channel Modulators Players by Revenue (2021-2026)
- 6.1.2 Global Ion Channel Modulators Revenue Market Share by Players (2021-2026)
- 6.2 Global Ion Channel Modulators Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Ion Channel Modulators Head Office and Area Served
- 6.4 Global Ion Channel Modulators Players, Product Type & Application
- 6.5 Global Ion Channel Modulators Manufacturers Established Date
- 6.6 Global Ion Channel Modulators Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Ion Channel Modulators Market Size (2021-2032)
- 7.2 North America Ion Channel Modulators Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Ion Channel Modulators Market Size by Country (2021-2026)
- 7.4 North America Ion Channel Modulators Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Ion Channel Modulators Market Size (2021-2032)
- 8.2 Europe Ion Channel Modulators Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Ion Channel Modulators Market Size by Country (2021-2026)
- 8.4 Europe Ion Channel Modulators Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Ion Channel Modulators Market Size (2021-2032)
- 9.2 Asia-Pacific Ion Channel Modulators Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Ion Channel Modulators Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Ion Channel Modulators Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Ion Channel Modulators Market Size (2021-2032)
- 10.2 South America Ion Channel Modulators Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Ion Channel Modulators Market Size by Country (2021-2026)
- 10.4 South America Ion Channel Modulators Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Ion Channel Modulators Market Size (2021-2032)
- 11.2 Middle East & Africa Ion Channel Modulators Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Ion Channel Modulators Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Ion Channel Modulators Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Sanofi (France)
- 12.1.1 Sanofi (France) Company Information
- 12.1.2 Sanofi (France) Business Overview
- 12.1.3 Sanofi (France) Revenue in Ion Channel Modulators Business (2021-2026)
- 12.1.4 Sanofi (France) Ion Channel Modulators Product Portfolio
- 12.1.5 Sanofi (France) Recent Developments
- 12.2 Pfizer, Inc. (US)
- 12.2.1 Pfizer, Inc. (US) Company Information
- 12.2.2 Pfizer, Inc. (US) Business Overview
- 12.2.3 Pfizer, Inc. (US) Revenue in Ion Channel Modulators Business (2021-2026)
- 12.2.4 Pfizer, Inc. (US) Ion Channel Modulators Product Portfolio
- 12.2.5 Pfizer, Inc. (US) Recent Developments
- 12.3 GlaxoSmithKline Plc. (UK)
- 12.3.1 GlaxoSmithKline Plc. (UK) Company Information
- 12.3.2 GlaxoSmithKline Plc. (UK) Business Overview
- 12.3.3 GlaxoSmithKline Plc. (UK) Revenue in Ion Channel Modulators Business (2021-2026)
- 12.3.4 GlaxoSmithKline Plc. (UK) Ion Channel Modulators Product Portfolio
- 12.3.5 GlaxoSmithKline Plc. (UK) Recent Developments
- 12.4 AstraZeneca (UK)
- 12.4.1 AstraZeneca (UK) Company Information
- 12.4.2 AstraZeneca (UK) Business Overview
- 12.4.3 AstraZeneca (UK) Revenue in Ion Channel Modulators Business (2021-2026)
- 12.4.4 AstraZeneca (UK) Ion Channel Modulators Product Portfolio
- 12.4.5 AstraZeneca (UK) Recent Developments
- 12.5 Zalicus, Inc. (US)
- 12.5.1 Zalicus, Inc. (US) Company Information
- 12.5.2 Zalicus, Inc. (US) Business Overview
- 12.5.3 Zalicus, Inc. (US) Revenue in Ion Channel Modulators Business (2021-2026)
- 12.5.4 Zalicus, Inc. (US) Ion Channel Modulators Product Portfolio
- 12.5.5 Zalicus, Inc. (US) Recent Developments
- 12.6 Xention Limited (UK)
- 12.6.1 Xention Limited (UK) Company Information
- 12.6.2 Xention Limited (UK) Business Overview
- 12.6.3 Xention Limited (UK) Revenue in Ion Channel Modulators Business (2021-2026)
- 12.6.4 Xention Limited (UK) Ion Channel Modulators Product Portfolio
- 12.6.5 Xention Limited (UK) Recent Developments
- 12.7 Targacept, Inc. (US)
- 12.7.1 Targacept, Inc. (US) Company Information
- 12.7.2 Targacept, Inc. (US) Business Overview
- 12.7.3 Targacept, Inc. (US) Revenue in Ion Channel Modulators Business (2021-2026)
- 12.7.4 Targacept, Inc. (US) Ion Channel Modulators Product Portfolio
- 12.7.5 Targacept, Inc. (US) Recent Developments
- 12.8 Parion Sciences, Inc. (US)
- 12.8.1 Parion Sciences, Inc. (US) Company Information
- 12.8.2 Parion Sciences, Inc. (US) Business Overview
- 12.8.3 Parion Sciences, Inc. (US) Revenue in Ion Channel Modulators Business (2021-2026)
- 12.8.4 Parion Sciences, Inc. (US) Ion Channel Modulators Product Portfolio
- 12.8.5 Parion Sciences, Inc. (US) Recent Developments
- 12.9 Novartis AG (Switzerland)
- 12.9.1 Novartis AG (Switzerland) Company Information
- 12.9.2 Novartis AG (Switzerland) Business Overview
- 12.9.3 Novartis AG (Switzerland) Revenue in Ion Channel Modulators Business (2021-2026)
- 12.9.4 Novartis AG (Switzerland) Ion Channel Modulators Product Portfolio
- 12.9.5 Novartis AG (Switzerland) Recent Developments
- 12.10 Neusentis, Inc. (US)
- 12.10.1 Neusentis, Inc. (US) Company Information
- 12.10.2 Neusentis, Inc. (US) Business Overview
- 12.10.3 Neusentis, Inc. (US) Revenue in Ion Channel Modulators Business (2021-2026)
- 12.10.4 Neusentis, Inc. (US) Ion Channel Modulators Product Portfolio
- 12.10.5 Neusentis, Inc. (US) Recent Developments
- 12.11 NeuroSearch A/S (Denmark)
- 12.11.1 NeuroSearch A/S (Denmark) Company Information
- 12.11.2 NeuroSearch A/S (Denmark) Business Overview
- 12.11.3 NeuroSearch A/S (Denmark) Revenue in Ion Channel Modulators Business (2021-2026)
- 12.11.4 NeuroSearch A/S (Denmark) Ion Channel Modulators Product Portfolio
- 12.11.5 NeuroSearch A/S (Denmark) Recent Developments
- 12.12 Nanion Technologies GmbH (Germany)
- 12.12.1 Nanion Technologies GmbH (Germany) Company Information
- 12.12.2 Nanion Technologies GmbH (Germany) Business Overview
- 12.12.3 Nanion Technologies GmbH (Germany) Revenue in Ion Channel Modulators Business (2021-2026)
- 12.12.4 Nanion Technologies GmbH (Germany) Ion Channel Modulators Product Portfolio
- 12.12.5 Nanion Technologies GmbH (Germany) Recent Developments
- 12.13 flyion GmbH (Germany)
- 12.13.1 flyion GmbH (Germany) Company Information
- 12.13.2 flyion GmbH (Germany) Business Overview
- 12.13.3 flyion GmbH (Germany) Revenue in Ion Channel Modulators Business (2021-2026)
- 12.13.4 flyion GmbH (Germany) Ion Channel Modulators Product Portfolio
- 12.13.5 flyion GmbH (Germany) Recent Developments
- 12.14 Evotec AG (Germany)
- 12.14.1 Evotec AG (Germany) Company Information
- 12.14.2 Evotec AG (Germany) Business Overview
- 12.14.3 Evotec AG (Germany) Revenue in Ion Channel Modulators Business (2021-2026)
- 12.14.4 Evotec AG (Germany) Ion Channel Modulators Product Portfolio
- 12.14.5 Evotec AG (Germany) Recent Developments
- 12.15 Cytocentrics AG (Germany)
- 12.15.1 Cytocentrics AG (Germany) Company Information
- 12.15.2 Cytocentrics AG (Germany) Business Overview
- 12.15.3 Cytocentrics AG (Germany) Revenue in Ion Channel Modulators Business (2021-2026)
- 12.15.4 Cytocentrics AG (Germany) Ion Channel Modulators Product Portfolio
- 12.15.5 Cytocentrics AG (Germany) Recent Developments
- 12.16 Convergence Pharmaceuticals Limited (UK)
- 12.16.1 Convergence Pharmaceuticals Limited (UK) Company Information
- 12.16.2 Convergence Pharmaceuticals Limited (UK) Business Overview
- 12.16.3 Convergence Pharmaceuticals Limited (UK) Revenue in Ion Channel Modulators Business (2021-2026)
- 12.16.4 Convergence Pharmaceuticals Limited (UK) Ion Channel Modulators Product Portfolio
- 12.16.5 Convergence Pharmaceuticals Limited (UK) Recent Developments
- 12.17 Cellectricon AB (Sweden)
- 12.17.1 Cellectricon AB (Sweden) Company Information
- 12.17.2 Cellectricon AB (Sweden) Business Overview
- 12.17.3 Cellectricon AB (Sweden) Revenue in Ion Channel Modulators Business (2021-2026)
- 12.17.4 Cellectricon AB (Sweden) Ion Channel Modulators Product Portfolio
- 12.17.5 Cellectricon AB (Sweden) Recent Developments
- 12.18 CalciMedica, Inc. (US)
- 12.18.1 CalciMedica, Inc. (US) Company Information
- 12.18.2 CalciMedica, Inc. (US) Business Overview
- 12.18.3 CalciMedica, Inc. (US) Revenue in Ion Channel Modulators Business (2021-2026)
- 12.18.4 CalciMedica, Inc. (US) Ion Channel Modulators Product Portfolio
- 12.18.5 CalciMedica, Inc. (US) Recent Developments
- 12.19 Aurora Biomed, Inc. (Canada)
- 12.19.1 Aurora Biomed, Inc. (Canada) Company Information
- 12.19.2 Aurora Biomed, Inc. (Canada) Business Overview
- 12.19.3 Aurora Biomed, Inc. (Canada) Revenue in Ion Channel Modulators Business (2021-2026)
- 12.19.4 Aurora Biomed, Inc. (Canada) Ion Channel Modulators Product Portfolio
- 12.19.5 Aurora Biomed, Inc. (Canada) Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst